Inducible overexpression of wild-type ASPP2 was not found to impact the growth rate, whereas phosphorylation-deficient ASPP2 exerted a moderate dominant negative effect on pancreatic cancer cell proliferation (Figure 4K,L). This evidence concerns the gene TP53BP2 and pancreatic neoplasm.